In the News
UC Berkeley News Center: Jennifer Doudna elected to the National Academy of Inventors
Three UC Berkeley, faculty members whose innovations have launched new startups and whole new areas of research have been named fellows of the National Academy of Inventors.
Xconomy: With Atlas Cash and Berkeley Tools, Intellia Joins the CRISPR Fray
Add another entrant to the race toward what might be called Gene Therapy 2.0. Atlas Venture and the research arm of the drug giant Novartis (NYSE: NVS) have put $15 million into the Series A round for Intellia Therapeutics, which is emerging today from stealth after two years of incubation.
Breakthrough Prize: Jennifer Doudna wins one of the 2015 Breakthrough Prizes in Life Sciences
The Breakthrough Prize Foundation tonight announced the recipients of the 2015 Breakthrough Prizes in Fundamental Physics and Life Sciences. These distinguished winners, along with previously announced recipients in the Mathematics category, each receive a $3 million prize.
GEN News: Guide RNA Gears of the CRISPR/Cas9 Machine Detailed
Although the CRISPR/Cas9 gene editing system is in wide use, its molecular basis still needs to be better understood. Of particular interest are molecular details that could account for the interactions between Cas9 and guide RNAs.
NPR: In Hopes of Fixing Faulty Genes, One Scientist Starts With the Basics
Whether they admit it or not, many (if not most) scientists secretly hope to get a call in October informing them they've won a Nobel Prize. But I've talked to a lot of Nobel laureates, and they are unanimous on one point: None of them pursued a research topic with the intention of winning the prize.